Lista de obras -

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

artículo científico publicado en 2015

A case of non-severe COVID-19 complicated by pulmonary embolism

artículo científico publicado en 2020

A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models.

artículo científico publicado en 2016

Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2

scientific article published on 14 September 2020

Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections

artículo científico publicado en 2020

Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses

scientific article published on 21 January 2020

Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension

artículo científico publicado en 2013

Characteristics of severe asthma with fungal sensitization

artículo científico publicado en 2017

Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study

scientific article published on 10 September 2020

Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry

artículo científico publicado en 2020

Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports

scientific article published on 01 August 2020

Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease.

artículo científico publicado en 2014

Dual role of interleukin-23 in epicutaneously-sensitized asthma in mice

artículo científico publicado en 2014

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2

artículo científico publicado en 2020

Group 2 innate lymphoid cells (ILC2s)

artículo científico publicado en 2015

Group 2 innate lymphoid cells and asthma

artículo científico publicado en 2015

Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2

artículo científico publicado en 2019

Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

artículo científico publicado en 2015

Isolation and analysis of group 2 innate lymphoid cells in mice.

artículo científico publicado en 2015

Left ventricular thrombus with COVID-19 complication in a patient with dilated cardiomyopathy

artículo científico publicado en 2020

Mechanisms to Suppress ILC2-induced Airway Inflammation

artículo científico publicado en 2016

Neuro-immune crosstalk and allergic inflammation

artículo científico publicado en 2019

Phenotype of asthma related with high serum periostin levels

artículo científico publicado en 2014

Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease

scientific article published on 29 November 2018

Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma

scientific article published on 21 June 2020

Subphenotypes of type 2 severe asthma in adults

artículo científico publicado en 2017

Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation

artículo científico publicado en 2020

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms

artículo científico publicado en 2018

The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.

artículo científico publicado en 2017

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

artículo científico publicado en 2013

Lista de obras de

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

A case of non-severe COVID-19 complicated by pulmonary embolism

A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models.

Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2

Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections

Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses

Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension

Characteristics of severe asthma with fungal sensitization

Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study

Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry

Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports

Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease.

Dual role of interleukin-23 in epicutaneously-sensitized asthma in mice

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2

Group 2 innate lymphoid cells (ILC2s)

Group 2 innate lymphoid cells and asthma

Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2

Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Isolation and analysis of group 2 innate lymphoid cells in mice.

Left ventricular thrombus with COVID-19 complication in a patient with dilated cardiomyopathy

Mechanisms to Suppress ILC2-induced Airway Inflammation

Neuro-immune crosstalk and allergic inflammation

Phenotype of asthma related with high serum periostin levels

Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease

Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma

Subphenotypes of type 2 severe asthma in adults

Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms

The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.